BioIntelliSense Closes Oversubscribed $45M Series B Financing Round to Scale Its Data-as-a-Service and Clinical Intelligence Platform
Venture capital and private equity bias—fueled in part by an aversion to small companies not aspiring to be billion-dollar venues—has choked the flow of cash to thousands of underrepresented...(PRWeb July 28, 2021)Read the full story
Intermediate Capital Group (ICG) has closed an initial EUR 1.45bn ESG-linked subscription facility for its eighth European direct lending fund, ICG Europe Fund VIII.
Europe was home to a record EUR 38bn's worth of venture and growth capital investment in the first half of 2021, shattering previous records, according to Unquote Data.
Healthcare venture capital funds are seeing more money flow in as startups quickly go public
Entrepreneurs grab new funds to hire more staff, expand market share